Radhika Manukonda
Overview
Explore the profile of Radhika Manukonda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
36
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Attem J, Narayana R, Manukonda R, Kaliki S, Vemuganti G
Biomed Pharmacother
. 2024 Mar;
173:116403.
PMID: 38490156
Drug resistance (DR) is one of the challenges in treating retinoblastoma (Rb) that warrants novel approaches. With the emerging evidence on the role of small extracellular vesicles (sEVs) as a...
2.
Gulati K, Manukonda R, Kairamkonda M, Kaliki S, Poluri K
ACS Omega
. 2023 Dec;
8(50):48233-48250.
PMID: 38144138
Retinoblastoma (Rb) is the most common pediatric eye cancer. To identify the biomarkers for early diagnosis and monitoring the progression of Rb in patients, mapping of the alterations in their...
3.
Manukonda R, Jakati S, Attem J, Mishra D, Mocherla T, Reddy M, et al.
Invest Ophthalmol Vis Sci
. 2023 Aug;
64(11):26.
PMID: 37603355
Purpose: To identify the genes and pathways responsible for treatment resistance (TR) in retinoblastoma (RB) by analyzing serum small extracellular vesicles (sEVs) of patients with TR active RB (TR-RB) and...
4.
Manukonda R, Narayana R, Kaliki S, Mishra D, Vemuganti G
Expert Opin Ther Targets
. 2022 Dec;
26(11):937-947.
PMID: 36524402
Introduction: Retinoblastoma (Rb) is an early childhood intraocular tumor of the retina and is managed by multimodal therapeutic approaches. Recent advanced targeted delivery of chemotherapeutic drugs to the eye has...
5.
Manukonda R, Yenuganti V, Nagar N, Dholaniya P, Malpotra S, Attem J, et al.
Cancers (Basel)
. 2022 Sep;
14(17).
PMID: 36077715
The present study employed nanoparticle tracking analysis, transmission electron microscopy, immunoblotting, RNA sequencing, and quantitative real-time PCR validation to characterize serum-derived small extracellular vesicles (sEVs) from RB patients and age-matched...
6.
Manukonda R, Attem J, Yenuganti V, Kaliki S, Vemuganti G
Tumour Biol
. 2022 Aug;
44(1):129-152.
PMID: 35964221
Exosomes are a subgroup of membrane-bound extracellular vesicles secreted by all cell types and present virtually in all biological fluids. The composition of exosomes in the same cell type varies...
7.
Nair R, Revu N, Gali S, Kallamadi P, Prabhu V, Manukonda R, et al.
Indian J Ophthalmol
. 2022 May;
70(5):1703-1711.
PMID: 35502056
Purpose: Cancer stem cells (CSCs) reported in various tumors play a crucial role in tumorigenesis and metastasis of retinoblastoma (Rb). Following the efforts to reduce, replace, and refine the use...
8.
Narayana R, Jana P, Tomar N, Prabhu V, Nair R, Manukonda R, et al.
Invest Ophthalmol Vis Sci
. 2021 Nov;
62(14):13.
PMID: 34784412
Purpose: Cancer stem cells (CSCs) are known to contribute to tumor relapses by virtue of their chemoresistance. With the knowledge that nanoformulations can overcome drug resistance, we evaluated the efficacy...
9.
Manukonda R, Pujar A, Ramappa G, Vemuganti G, Kaliki S
Ophthalmic Genet
. 2021 Oct;
43(1):64-72.
PMID: 34645364
Background: Retinoblastoma (RB) is an intraocular childhood cancer develops due to inactivation of RB1 gene. Identification of RB1 genetic variants, correlating and confirming genetic test results with clinical outcomes are...
10.
Nair R, Prabhu V, Manukonda R, Mishra D, Kaliki S, Vemuganti G
Tumour Biol
. 2020 Nov;
42(11):1010428320975973.
PMID: 33245030
Introduction: Metastasis-associated in colon cancer 1 (MACC1), one of the prognostic markers for colonic and other tumours was noted to be overexpressed in retinoblastoma (Rb) Y79 cancer stem cells. This...